|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsored by: |
Stanford University |
| Information provided by: | Stanford University |
| ClinicalTrials.gov Identifier: | NCT00550368 |
Purpose
The study proposes to test whether chronic infection with Helicobacter pylori protects individuals from symptomatic infection with enteropathogenic E. coli. The study will also evaluate the effect of gastric acidity in this relationship.
| Condition | Intervention |
|
Infection Achlorhydria |
Biological: Biological intervention: Enteropathogenic E. coli |
| MedlinePlus related topics: | Diarrhea |
| Study Type: | Interventional |
| Study Design: | Prevention, Non-Randomized, Open Label, Active Control, Single Group Assignment, Efficacy Study |
| Official Title: | Effect of Gastric Acid and H. Pylori Infection on Infection With Enteropathogenic E. Coli |
Eligibility
| Ages Eligible for Study: | 35 Years to 59 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:Healthy Exclusion Criteria:prior gastrointestinal disease prior treatment of H. pylori infection immune suppression or deficiency history of cancer, diabetes, or other co-morbidity
Contacts and Locations| United States, California | |||||
| Stanford University School of Medicine | |||||
| Stanford, California, United States, 94305 | |||||
| Stanford University |
| Principal Investigator: | Julie Parsonnet | Stanford University |
More Information
| Study ID Numbers: | 688 |
| First Received: | October 25, 2007 |
| Last Updated: | June 16, 2008 |
| ClinicalTrials.gov Identifier: | NCT00550368 |
| Health Authority: | USA:Institutional Review Board |
|
|
|